Pilot Program Aims to Improve Efficiencies in Treatment of Hepatitis C

PURCHASE, N.Y. - January 18, 2017 - Mastercard has signed a Memorandum of Understanding (MoU) with Gilead Sciences, Inc. to explore the potential use of the Mastercard Aid Network to simplify the delivery of hepatitis C treatment in a resource limited setting with high disease burden.

The Mastercard Aid Network is a non-financial digital solution that helps facilitate the distribution and tracking of aid funds. Organizations such as World Vision and Save the Children have successfully used this technology for emergency and ongoing humanitarian relief efforts in the Philippines and Yemen.

The collaboration with Gilead is the first instance where the closed-loop, points-based Mastercard Aid Network would be used in a healthcare context.

An estimated 150 million people worldwide are infected with hepatitis C, with the vast majority of those people living in low- and lower-middle income countries. Many of these countries lack government funded national treatment programs for hepatitis C, the majority of healthcare expenditure being through out-of-pocket payments.

'This initiative builds on an ongoing effort to use our technology to advance the Sustainable Development Goals - and to enable people to lead better, more autonomous lives', said Leigh Amaro, senior vice president, Enterprise Partnerships, Mastercard. 'In slightly more than a year, the Mastercard Aid Network has helped international aid organizations increase their impact in some of the most distressed communities. By combining our digital technology with Gilead's medical expertise, we look to have the same effect in delivering health services to those people who need it the most.'

Under the MoU, the parties will discuss the development of a digitized tool, including a monitoring and evaluation feature, that healthcare providers can use in a small-scale pilot to facilitate successful treatment outcomes.

'Our goal is to expand access to effective treatment for chronic hepatitis C', said Gregg Alton, executive vice president, Corporate and Medical Affairs, Gilead Sciences. 'In exploring the potential use of this technology in a resource poor setting, we hope to better provide essential medicines and services to patients.'

'Unlike in so many disease areas, in hepatitis C we have a cure', said Charles Gore, president of the World Hepatitis Alliance. 'The issue is facilitating affordable access to treatment for the tens of millions who need it. We have to explore smart and innovative mechanisms that simplify the treatment process, cut out inefficiencies and help drive down costs. This initiative, which combines access to hepatitis C treatment with the Mastercard Aid Network platform and civil society's ability to deliver on the ground, is exactly the sort of public-private partnership that we need to explore.'

Note to editors

This is how the Mastercard Aid Network works:

  • The Mastercard Aid Network consists of Android-enabled devices, card readers, and EMV standard chip cards
  • Android-enabled devices run specially built applications tailored to both implementer field staff and service providers
  • Implementers set up and manage programs via a portal that may provide a simple and powerful tool for monitoring and evaluation of treatment outcomes
  • Backed by Mastercard safety and security, non-financial, non-personalized 'interactions' are authenticated via PIN and processed entirely offline
  • Service providers periodically synchronize their terminals in order to receive updates and send 'interaction' histories to the implementer

About Mastercard

Mastercard (NYSE: MA), www.mastercard.com, is a technology company in the global payments industry. We operate the world's fastest payments processing network, connecting consumers, financial institutions, merchants, governments and businesses in more than 210 countries and territories. Mastercard products and solutions make everyday commerce activities - such as shopping, traveling, running a business and managing finances - easier, more secure and more efficient for everyone. Follow us on Twitter @MastercardNews, join the discussion on the Beyond the Transaction Blog and subscribe for the latest news on the Engagement Bureau.

Mastercard Communications Contact

Bernhard Mors, + 1 914 325 9676
bernhard.mors@mastercard.com

MasterCard Inc. published this content on 18 January 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 18 January 2017 14:06:15 UTC.

Original documenthttp://newsroom.mastercard.com/press-releases/mastercard-and-gilead-sciences-to-explore-digitized-healthcare-model-in-resource-limited-setting/

Public permalinkhttp://www.publicnow.com/view/B464F0F02C0D4677038D08DCD8B0A833445E8EF6